California Public Employees Retirement System’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,300
Closed -$931K 3049
2021
Q1
$931K Sell
22,300
-2,034
-8% -$94.4K ﹤0.01% 2555
2020
Q4
$1.13M Sell
24,334
-500
-2% -$23.4K ﹤0.01% 2388
2020
Q3
$1.05M Sell
24,834
-58
-0.2% -$2.54K ﹤0.01% 2252
2020
Q2
$1.19M Buy
24,892
+4,313
+21% +$215K ﹤0.01% 2112
2020
Q1
$947K Sell
20,579
-35,695
-63% -$1.79M ﹤0.01% 2047
2019
Q4
$3.38M Buy
56,274
+51,395
+1,053% +$3.06M ﹤0.01% 1716
2019
Q3
$276K Buy
+4,879
New +$274K ﹤0.01% 2790
2018
Q4
Sell
-2,970
Closed -$206K 3272
2018
Q3
$206K Buy
2,970
+216
+8% +$16.4K ﹤0.01% 3014
2018
Q2
$208K Buy
+2,754
New +$173K ﹤0.01% 2988
2016
Q2
Sell
-8,600
Closed -$348K 3573
2016
Q1
$348K Sell
8,600
-3,900
-31% -$247K ﹤0.01% 2895
2015
Q4
$1.11M Sell
12,500
-6,400
-34% -$505K ﹤0.01% 2319
2015
Q3
$1.4M Buy
18,900
+8,900
+89% +$740K ﹤0.01% 2159
2015
Q2
$809K Buy
+10,000
New +$651K ﹤0.01% 2633

Other funds holding EGRX

California Public Employees Retirement System's EGRX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2021, closing a stake of 22,300 shares — an estimated $931K sold.

California Public Employees Retirement System first reported a position in EGRX in Q2 2015 and held it in 13 quarters. The position peaked at $3.38M in Q4 2019. 146 funds tracked by Wall St. Rank hold EGRX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 22,300 Eagle Pharmaceuticals, Inc. shares in Q2 2021, an estimated $931K.
  • California Public Employees Retirement System first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
  • California Public Employees Retirement System's Eagle Pharmaceuticals, Inc. position peaked at $3.38M in Q4 2019.
  • 146 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.